AI
SWAV

Axiom Investors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Axiom Investors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,493
Closed -$3.14M – 150
2023
Q4 		$3.14M Buy
16,493
+9,403
+133% +$1.78M 0.03% 116
2023
Q3 		$1.41M Sell
7,090
-12,437
-64% -$2.94M 0.02% 110
2023
Q2 		$5.57M Buy
19,527
+297
+2% +$82.5K 0.08% 77
2023
Q1 		$4.17M Sell
19,230
-730
-4% -$142K 0.07% 87
2022
Q4 		$4.1M Sell
19,960
-8,120
-29% -$2.05M 0.08% 87
2022
Q3 		$7.81M Buy
+28,080
New +$7.14M 0.16% 71

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Axiom Investors's SWAV Position: Q1 2024 in Review

Axiom Investors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 16,493 shares — an estimated $3.14M sold.

Axiom Investors first reported a position in SWAV in Q3 2022 and held it in 6 quarters. The position peaked at $7.81M in Q3 2022. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Axiom Investors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Axiom Investors sold 16,493 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $3.14M.
  • Axiom Investors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Axiom Investors's Shockwave Medical, Inc. Common Stock position peaked at $7.81M in Q3 2022.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Axiom Investors's 13F filing for Q1 2024, filed 13 May 2024.